Grindeks is the leading pharmaceutical company in the Baltic states. Main fields of action are research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients. Grindeks specializes in the heart and cardiovascular, CNS and anti-cancer medication therapeutic groups. Grindeks Group consists of 4 subsidiary companies in Latvia, Estonia and Russia; representative offices are opened in 10 countries. Products are exported to 50 countries, export comprises 95% of the total turnover. The main markets are the Baltic States, Russia and other CIS countries, Germany, the Netherlands, Japan.